
Jiangsu gdk Biotechnology Co., Ltd.
SSE:688670.SS
13.52 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Jiangsu gdk Biotechnology Co., Ltd. |
Symbool | 688670.SS |
Munteenheid | CNY |
Prijs | 13.52 |
Beurswaarde | 1,665,664,000 |
Dividendpercentage | 1.14% |
52-weken bereik | 9.36 - 17.67 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jun Yu |
Website | https://www.gdkbio.com |
An error occurred while fetching data.
Over Jiangsu gdk Biotechnology Co., Ltd.
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)